SCHEMBL7256176

SCHEMBL7256176

CCOC(=O)/C=C/C1(c2ccc(OC)c3c2OCCO3)CCC(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 1/20 0.43
FDPS P14324 1/20 0.37
MAPT P10636 2/20 0.36
MAOB P27338 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CNKSR1 Q969H4 1/20 0.34
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
ACHE P22303 4/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7256179 1.00 LMNA (0.43) LMNAALDH1A1KDM4EHSD17B10FDPS
SCHEMBL7249854 0.87 KDM4E (0.46) LMNAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL7249855 0.87 KDM4E (0.46) LMNAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL7495323 0.87 ALDH1A1 (0.42) LMNAALDH1A1KDM4EHSD17B10FDPS
SCHEMBL7250234 0.87 ALDH1A1 (0.42) LMNAALDH1A1KDM4EHSD17B10FDPS
SCHEMBL7256677 0.86 LMNA (0.45) LMNAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL7256680 0.86 LMNA (0.45) LMNAALDH1A1KDM4EHSD17B10MAPT
Ethylene SCHEMBL7253122 0.78 PDE4D (0.44) LMNAALDH1A1KDM4EHSD17B10MAPT
Ethylene SCHEMBL7250517 0.78 LMNA (0.44) LMNAALDH1A1KDM4EHSD17B10MAPT
SCHEMBL7252431 0.77 ALDH1A1 (0.43) LMNAALDH1A1KDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030100772-A1 Oxygen-containing heterocyclic compounds KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-05-29 US disclosed
EP-1264829-A1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100772-A1 Oxygen-containing heterocyclic compounds CBR1, CYP11B2, CBR3 LMNA 4580/4885ALDH1A1 263/4885KDM4E 1212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.